Effect of Non-alcoholic Fatty Liver Disease on Kidney Functions
NCT03172650 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2017-08-16
Summary
Non-alcoholic fatty liver disease is the most common cause of chronic liver disease worldwide. It is defined as the accumulation of fat (\>5%) in the liver cells in the absence of excessive alcohol intake or other causes of liver disease including viral, drug-induced, or autoimmune. Non-alcoholic fatty liver disease is a hepatic manifestation of metabolic syndrome.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
glomerular filtration rate
collection of blood sample 5 milliliter for calculation of glomerular filtration rate
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-01
- Primary Completion
- 2018-07-31
- Completion
- 2018-09-30
Countries
- Egypt
More Related Trials
-
Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut.
NCT07144501 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Neutrophil to Lymphocyte Ratio and Mean Platelet Volume as a Prognostic Predictor Among Patients With Acute on Top of Chronic Liver Cell Failure
NCT06857682 ·Status: ACTIVE_NOT_RECRUITING
-
Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
NCT07053709 ·Status: NOT_YET_RECRUITING
-
Pattern of Acute on Chronic Liver Failure in Patient With HCV Related Chronic Liver Disease
NCT03456518 ·Status: COMPLETED
-
Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD Individuals
NCT05245890 ·Status: UNKNOWN
-
Hepatic Manifestations and Effect of Long COVID-19 on Patients With Chronic Liver Disease
NCT04998214 ·Status: UNKNOWN
-
Acute on Chronic Liver Failure in Cirrhotic Patients at Assiut University Hospitals
NCT06142968 ·Status: NOT_YET_RECRUITING
-
Short Term Outcomes in Hospitalized Patients With Liver Cirrhosis
NCT05848414 ·Status: COMPLETED
-
Stratification of Chronic Alcoholic Liver Diseases (SCALE Study)
NCT03295812 ·Status: UNKNOWN
-
Optimal Clinical Predictors to AKI in Cirrhotic Patients Experienced Acute Gastrointestinal Hemorrhage
NCT04184934 ·Status: UNKNOWN
-
Von Willebrand Factor Levels in Patients With Liver Cirrhosis and Portal Hypertension
NCT06694090 ·Status: NOT_YET_RECRUITING
-
Assessment Of Lipid Profile In Cirrhotic Patients
NCT04788173 ·Status: COMPLETED
-
Acute-On-Chronic Liver Failure In Cirrhotic Patients
NCT04790435 ·Status: COMPLETED
-
NAFLD Clinical Care Pathway
NCT06671886 ·Status: RECRUITING ·Phase: NA
-
Acute-On-Chronic Liver Failure in Zagazig University Hospitals
NCT03184636 ·Status: COMPLETED
-
Correlation of Platelets Count With Endoscopic Findings in a Cohort of Egyptian Patients With Liver Cirrhosis
NCT02621372 ·Status: UNKNOWN
-
Platelet Indices in Decompensated Post Hepatitic Liver Cirrhosis
NCT04126447 ·Status: UNKNOWN
-
A Retrospective Multicenter Study of HBV-related Pre-acute-on-chronic Liver Failure in China
NCT03281265 ·Status: COMPLETED
-
Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
NCT05772585 ·Status: WITHDRAWN
-
Assessment of Hemostatic Profile in Liver Cirrhosis
NCT04265508 ·Status: COMPLETED
-
Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients
NCT06666894 ·Status: COMPLETED ·Phase: NA
-
Haemostatic Imbalance in Patients With Chronic Liver Disease
NCT03589430 ·Status: UNKNOWN
-
Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF
NCT05421351 ·Status: UNKNOWN
-
Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients
NCT05228509 ·Status: RECRUITING
-
Elevated Liver Enzymes as a Predictor of Acute Kidney Injury in Hospitalized Patients With COVID-19
NCT05157152 ·Status: UNKNOWN